Hong Kong · Delayed Price · Currency is HKD Bayzed Health Group Statistics
Total Valuation
HKG:2609 has a market cap or net worth of HKD 3.67 billion. The enterprise value is 3.76 billion.
| Market Cap | 3.67B |
| Enterprise Value | 3.76B |
Important Dates
The next estimated earnings date is Friday, November 27, 2026.
| Earnings Date | Nov 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2609 has 1.32 billion shares outstanding. The number of shares has increased by 0.28% in one year.
| Current Share Class | 1.32B |
| Shares Outstanding | 1.32B |
| Shares Change (YoY) | +0.28% |
| Shares Change (QoQ) | +10.58% |
| Owned by Insiders (%) | 51.75% |
| Owned by Institutions (%) | 18.37% |
| Float | 595.76M |
Valuation Ratios
The trailing PE ratio is 104.70.
| PE Ratio | 104.70 |
| Forward PE | n/a |
| PS Ratio | 2.83 |
| PB Ratio | 1.97 |
| P/TBV Ratio | 4.87 |
| P/FCF Ratio | 14.93 |
| P/OCF Ratio | 12.18 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.79, with an EV/FCF ratio of 15.29.
| EV / Earnings | 112.64 |
| EV / Sales | 2.90 |
| EV / EBITDA | 21.79 |
| EV / EBIT | 60.76 |
| EV / FCF | 15.29 |
Financial Position
The company has a current ratio of 1.69, with a Debt / Equity ratio of 0.33.
| Current Ratio | 1.69 |
| Quick Ratio | 1.58 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 3.57 |
| Debt / FCF | 2.51 |
| Interest Coverage | 2.59 |
Financial Efficiency
Return on equity (ROE) is 1.85% and return on invested capital (ROIC) is 2.24%.
| Return on Equity (ROE) | 1.85% |
| Return on Assets (ROA) | 1.30% |
| Return on Invested Capital (ROIC) | 2.24% |
| Return on Capital Employed (ROCE) | 2.92% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 640,500 |
| Profits Per Employee | 16,490 |
| Employee Count | 2,036 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 15.05 |
Taxes
In the past 12 months, HKG:2609 has paid 17.47 million in taxes.
| Income Tax | 17.47M |
| Effective Tax Rate | 33.49% |
Stock Price Statistics
The stock price has decreased by -60.84% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -60.84% |
| 50-Day Moving Average | 2.98 |
| 200-Day Moving Average | 3.82 |
| Relative Strength Index (RSI) | 38.77 |
| Average Volume (20 Days) | 1,709,670 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2609 had revenue of HKD 1.30 billion and earned 33.57 million in profits. Earnings per share was 0.03.
| Revenue | 1.30B |
| Gross Profit | 222.88M |
| Operating Income | 62.24M |
| Pretax Income | 52.16M |
| Net Income | 33.57M |
| EBITDA | 140.28M |
| EBIT | 62.24M |
| Earnings Per Share (EPS) | 0.03 |
Balance Sheet
The company has 649.87 million in cash and 619.93 million in debt, with a net cash position of 29.94 million or 0.02 per share.
| Cash & Cash Equivalents | 649.87M |
| Total Debt | 619.93M |
| Net Cash | 29.94M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 1.88B |
| Book Value Per Share | 1.33 |
| Working Capital | 541.78M |
Cash Flow
In the last 12 months, operating cash flow was 303.15 million and capital expenditures -55.83 million, giving a free cash flow of 247.33 million.
| Operating Cash Flow | 303.15M |
| Capital Expenditures | -55.83M |
| Depreciation & Amortization | 79.28M |
| Net Borrowing | -301.99M |
| Free Cash Flow | 247.33M |
| FCF Per Share | 0.19 |
Margins
Gross margin is 17.09%, with operating and profit margins of 4.77% and 2.57%.
| Gross Margin | 17.09% |
| Operating Margin | 4.77% |
| Pretax Margin | 4.00% |
| Profit Margin | 2.57% |
| EBITDA Margin | 10.76% |
| EBIT Margin | 4.77% |
| FCF Margin | 18.67% |
Dividends & Yields
HKG:2609 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.28% |
| Shareholder Yield | -0.28% |
| Earnings Yield | 0.91% |
| FCF Yield | 6.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:2609 has an Altman Z-Score of 4.88 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.88 |
| Piotroski F-Score | 6 |